Viewpoints

ASCO Advance of the Year: Immunotherapy 2.0

ASCO Advance of the Year: Immunotherapy 2.0

The American Society of Clinical Oncology (ASCO) named Immunotherapy 2.0 the "advance of the year."

Determining the Role of Gender in Oncology Trial and Treatment Outcomes

Determining the Role of Gender in Oncology Trial and Treatment Outcomes

Differences between the sexes are known in a variety of cancers, but the reasons remain unclear.

Feature Articles

Survival After Pediatric Cancer: Reducing the Lifetime Burden

Survival After Pediatric Cancer: Reducing the Lifetime Burden

A study of self-reported health status shows the need for physicians to consider the overall well-being of pediatric cancer survivors, for life.

Pancreatic Cancer Resources

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters